Show simple item record

dc.contributor.authorVogel, JP
dc.contributor.authorSouza, JP
dc.contributor.authorGülmezoglu, MA
dc.contributor.authorMori, R
dc.contributor.authorLumbiganon, P
dc.contributor.authorQureshi, Zahida
dc.contributor.authorCarroli, G
dc.contributor.authorFawole, B
dc.contributor.authorGanchimeg, T
dc.contributor.authorZhang, J
dc.contributor.authorTorloni, MR
dc.contributor.authorBohren, M
dc.date.accessioned2014-12-14T08:03:31Z
dc.date.available2014-12-14T08:03:31Z
dc.date.issued2014
dc.identifier.citationVogel JP, Souza JP, Gülmezoglu MA, Mori R, Lumbiganon P, QURESHI ZAHIDA, Carroli G, Laopaiboon M, Fawole B, Ganchimeg T, Zhang J, Torloni MR, Bohren M, Temmerman M. "Use of antenatal corticosteroids and tocolytic drugs in preterm births in 29 countries: an analysis of the WHO Multicountry Survey on Maternal and Newborn Health." Lancet. 2014;384(9957):1869-77.en_US
dc.identifier.urihttp://hdl.handle.net/11295/77533
dc.description.abstractDespite the global burden of morbidity and mortality associated with preterm birth, little evidence is available for use of antenatal corticosteroids and tocolytic drugs in preterm births in low-income and middle-income countries. We analysed data from the WHO Multicountry Survey on Maternal and Newborn Health (WHOMCS) to assess coverage for these interventions in preterm deliveriesen_US
dc.language.isoenen_US
dc.publisherUniversity of Nairobien_US
dc.titleUse of antenatal corticosteroids and tocolytic drugs in preterm births in 29 countries: an analysis of the who multicountry survey on maternal and newborn healthen_US
dc.typeArticleen_US
dc.type.materialenen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record